Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$27,000.00

Mechanisms in RiPP Natural Product Biosynthesis

FY 2018-19

Summary
Natural products are chemical compounds made by living organisms that serve numerous biological, ecological, and anthropological functions most notably as medicines to treat a variety of human illnesses. Indeed, the majority of all drugs approved for human use by the US Food and Drug Administration are either natural products or are synthetic derivatives of natural products, clearly underscoring the importance of these molecules to the quality of human life in the 21st century. In recent years, however, many of the natural products that have been traditionally used to treat human bacterial infections have lost their effectiveness due to the widespread emergence of antimicrobial resistance. In light of this daunting threat, renewed efforts in discovering and developing novel antimicrobial natural products are urgently needed. The proposed research program seeks to address this growing crisis through several distinct, but cohesive research directions that aim to illuminate the mechanistic principles of the enzymes that construct natural products. Initial studies will be focused on developing several emerging biophysical methods to characterize biosynthetic enzymes from unique perspectives. These studies will provide a molecular mechanistic understanding of what enables biosynthetic enzymes to perform their functions, and will provide insights into how those functions may potentially be manipulated for synthetic purposes. In addition, the program will identify and characterize molecules with unusual structures and enzymes with unusual functions, as potential avenues for identifying new antimicrobial compounds and new tools for the structural modification of compounds, respectively. Altogether, understanding*natural product biosynthesis on a molecular mechanistic level provides a*critical foundation for guiding the characterization of new natural products, for the rational*engineering of structures that do not exist in nature, a-nd for the targeted production of molecules of interest. As such, the proposed research program is expected to greatly benefit the ongoing and mounting struggle to combat drug resistant human pathogens - an endeavor of immense importance to the people of Canada and across the world.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2017-04485
Name nom
Thibodeaux, Christopher
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
2
Nb partie
5
Application title
Mechanisms in RiPP Natural Product Biosynthesis
Keyword
NSERC
Application summary
Natural products are chemical compounds made by living organisms that serve numerous biological, ecological, and anthropological functions most notably as medicines to treat a variety of human illnesses. Indeed, the majority of all drugs approved for human use by the US Food and Drug Administration are either natural products or are synthetic derivatives of natural products, clearly underscoring the importance of these molecules to the quality of human life in the 21st century. In recent years, however, many of the natural products that have been traditionally used to treat human bacterial infections have lost their effectiveness due to the widespread emergence of antimicrobial resistance. In light of this daunting threat, renewed efforts in discovering and developing novel antimicrobial natural products are urgently needed. The proposed research program seeks to address this growing crisis through several distinct, but cohesive research directions that aim to illuminate the mechanistic principles of the enzymes that construct natural products. Initial studies will be focused on developing several emerging biophysical methods to characterize biosynthetic enzymes from unique perspectives. These studies will provide a molecular mechanistic understanding of what enables biosynthetic enzymes to perform their functions, and will provide insights into how those functions may potentially be manipulated for synthetic purposes. In addition, the program will identify and characterize molecules with unusual structures and enzymes with unusual functions, as potential avenues for identifying new antimicrobial compounds and new tools for the structural modification of compounds, respectively. Altogether, understanding*natural product biosynthesis on a molecular mechanistic level provides a*critical foundation for guiding the characterization of new natural products, for the rational*engineering of structures that do not exist in nature, a-nd for the targeted production of molecules of interest. As such, the proposed research program is expected to greatly benefit the ongoing and mounting struggle to combat drug resistant human pathogens - an endeavor of immense importance to the people of Canada and across the world.